Optimal pharmacotherapy to combat the atherogenic lipid triad.
Saved in:
| Title: | Optimal pharmacotherapy to combat the atherogenic lipid triad. |
|---|---|
| Authors: | Chapman MJ; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research, Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr, Redfern JS, McGovern ME, Giral P |
| Source: | Current opinion in cardiology [Curr Opin Cardiol] 2011 Sep; Vol. 26 (5), pp. 403-11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Lippincott Williams and Wilkins Country of Publication: United States NLM ID: 8608087 Publication Model: Print Cited Medium: Internet ISSN: 1531-7080 (Electronic) Linking ISSN: 02684705 NLM ISO Abbreviation: Curr Opin Cardiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
